Dr. Krishna M. Malireddi, MD

Dr. Malireddi practices at Rockwood Clinic PS in Spokane, Washington.

Dr. Malireddi's NPI, 1780778746, was assigned on October 3, 2006. Dr. Malireddi holds Washington license MD00041214.

Dr. Malireddi's primary practice is Rockwood Clinic PS, at 105 W 8th Ave, Spokane, WA 99204 in Spokane County. The practice phone is (509) 838-2531.

Dr. Malireddi's primary practice is Rockwood Clinic PS in Spokane, Washington. Dr. Malireddi is also affiliated with Prov Sacred Hrt Med Ctr & Childs Hosp. The medical group on file is Providence Medical Group. Dmand AI also links Dr. Malireddi to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Malireddi practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Malireddi's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Malireddi is licensed in Washington.

CMS data shows 638 Medicare services from Dr. Malireddi across 4 procedure codes in 2024, for 134 Medicare patients. Medicare paid $37,175 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 134 Medicare patients who saw Dr. Malireddi in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 35% are also on Medicaid. Their average risk score is 5.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Malireddi's median patient age at 64, with 43% women.

In 2024, Dr. Malireddi wrote 269 Medicare Part D claims for 54 patients. 94% of them were for generic drugs. CMS names the drug for 196 of them, across 8 drugs with 11 or more claims each, at $4,877 in total drug cost. In 2023, CMS named 856 claims across 22 drugs.

Dr. Malireddi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 99 general payments to Dr. Malireddi from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Keryx Biopharmaceuticals, Inc. paid the most, $1,026.